Status:
COMPLETED
Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural Effusion
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Community Acquired Pneumonia
Eligibility:
All Genders
17-80 years
Brief Summary
Key words : serum, pleural effusion, procalcitonin, pneumonia Pneumonia is the common cause of pleural effusion (ranged 2nd) and bacterial infection is the main etiology of pneumonia. Procalcitonin, t...
Detailed Description
In this study, the first goal will be to determine the sensitivity, specificity, and predictive value of serum and pleural effusion PCT level in CAP with pleural effusion. The second goal will be to d...
Eligibility Criteria
Inclusion
- A consecutive series of patients (17 years or older) who present to our hospital with suspected CAP with pleural effusion in the planning duration will be studied. All study cases had not received systemic or topical antimicrobial therapy during the 3 days before the study and they had never smoked at least one cigarette per day for 1 year. A case will be enrolled subsequently by the diagnosis of CAP with pleural effusion from clinical pneumonia infection score (CPIS) and chest sonography.
Exclusion
- Patients with known thyroid disease or small cell lung cancer will be excluded.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00646490
Start Date
July 1 2005
End Date
July 1 2009
Last Update
February 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Kaohsiung
Kaohsiung City, Kaohsiung, Taiwan, 833